|
|
 |
|
Viewing report
|
|
|
|
Industry Report Card: U.S. Health Care Apr 03
Standard & Poors, April 2003
Abstract
The largely domestic nature of health care services, and sustained demand for innovative drug and medical device therapies, is expected to provide relative stability for U.S. health care companies amidst current economic uncertainty. Undoubtedly, in the longer term, payor pressures related to the expense of buying increasingly costly medical therapies for an aging population with greater health needs will continue as a significant risk factor. However, in the meantime, corporate health care activity in the months ahead is likely to feature a variable pattern of rating and outlook actions that will be more tied to company-specific events, rather than to developments in the industry as a whole. In terms of recent credit activity, the year 2003 has begun in a...
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.
|
|
|
|
